Home › Funds › NEXTBio Capital Management LP › ORIC
NEXTBio Capital Management LP position in ORIC
ORIC PHARMACEUTICALS INC · Health Care
NEXTBio Capital Management LP reported holding 684,476 shares of ORIC (ORIC PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$9.2M, representing 4.01% of its reported portfolio and ranking #11 among its reported holdings. NEXTBio Capital Management LP has disclosed ORIC holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How NEXTBio Capital Management LP's ORIC position evolved
NEXTBio Capital Management LP first disclosed a stake in ORIC in Q4 2025 at 615,720 shares (US$5.0M). The position peaked in Q3 2026 at 684,476 shares, worth US$9.2M. Across 4 filings, NEXTBio Capital Management LP increased the stake 1 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 684,476 shares valued at US$9.2M — a reduction of -21,648 shares quarter over quarter.. Notable position changes include a 35% increase in Q2 2026 (shares rose 24% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 615.72K | $5.04M | New |
| Q1 2026 | 523.62K | $6.63M | Reduce |
| Q2 2026 | 706.12K | $7.65M | Add |
| Q3 2026 | 684.48K | $9.22M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ORIC and 13F data
ORIC (ORIC PHARMACEUTICALS INC) is a Health Care company. 41 other funds we track also report a position in ORIC — the largest reported positions include Nextech Invest Ltd. (US$77.6M), EcoR1 Capital, LLC (US$72.9M), SR ONE CAPITAL MANAGEMENT, LP (US$50.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ORIC
- Nextech Invest Ltd. 7.16M sh · $77.57M · Q2 2026
- EcoR1 Capital, LLC 6.73M sh · $72.87M · Q2 2026
- SR ONE CAPITAL MANAGEMENT, LP 4.62M sh · $49.98M · Q2 2026
- Venrock Adviser, LLC 4.32M sh · $46.78M · Q2 2026
- Siren, L.L.C. 3.36M sh · $45.23M · Q3 2026
- NEA Management Company, LLC 4.12M sh · $44.60M · Q2 2026
- AIHC Capital Management Ltd 3.83M sh · $41.46M · Q2 2026
- Column Group LLC 3.54M sh · $38.35M · Q2 2026
- First Turn Management, LLC 2.02M sh · $21.85M · Q2 2026
- Integral Health Asset Management, LLC 1.90M sh · $20.58M · Q2 2026
- MPM BioImpact LLC 1.88M sh · $20.38M · Q2 2026
- Vivo Capital, LLC 924.39K sh · $12.45M · Q3 2026
More on NEXTBio Capital Management LP
FAQ
How long has NEXTBio Capital Management LP held ORIC?
NEXTBio Capital Management LP has disclosed ORIC holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
What is NEXTBio Capital Management LP's current position in ORIC?
As of Q3 2026, NEXTBio Capital Management LP holds 684.48K shares of ORIC (ORIC PHARMACEUTICALS INC), valued at $9.22M, representing 4.01% of its reported portfolio and ranking #11.
Has NEXTBio Capital Management LP been buying or selling ORIC?
In the latest 13F filing (Q3 2026), NEXTBio Capital Management LP reduced its position in ORIC. The position peaked in Q3 2026 at 684.48K shares.
Which other funds hold ORIC?
Other major institutional holders of ORIC include Nextech Invest Ltd., EcoR1 Capital, LLC, SR ONE CAPITAL MANAGEMENT, LP, among 41 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.